Form 4: AdaptHealth CLO Acquires 53,688 Restricted Stock Units

AdaptHealth Corp.'s CLO and General Counsel, Richard W. Rew II, acquired 53,688 restricted stock units, increasing his beneficial ownership to 102,097 shares.

Summary

• Richard W. Rew II, the Chief Legal Officer (CLO) and General Counsel of AdaptHealth Corp. (AHCO), acquired 53,688 shares of common stock.
• These shares represent restricted stock units (RSUs) that will be settled in common stock upon vesting.
• The transaction occurred on January 30, 2026, with an acquisition price of $0 per share.
• Following this transaction, Mr. Rew beneficially owns a total of 102,097 shares of AdaptHealth Corp. common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as an executive increasing their stake, even through an RSU grant, generally indicates confidence in the company's future prospects and aligns management's interests with shareholders.

Positives

• The acquisition of 53,688 restricted stock units by a key executive, Richard W. Rew II, demonstrates continued alignment of management interests with shareholder value.
• The increase in beneficial ownership to 102,097 shares indicates a significant equity stake held by the CLO and General Counsel.

Industry Context

StockSavvy.ai notes that insider acquisitions of restricted stock units are a common form of executive compensation, aligning management incentives with long-term company performance. This specific grant to AdaptHealth's CLO is consistent with typical practices in the healthcare services industry for retaining key talent.

Stakeholder Impact

• Shareholders: Increased alignment of executive interests with shareholder value due to the executive's increased equity stake.

Next Steps

• Vesting of the restricted stock units, at which point they will be settled in common stock.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of restricted stock units to a key executive. While it indicates management's continued alignment with the company's performance, it does not provide new fundamental information about the company's operations, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

AdaptHealth Corp., AHCO, Richard W. Rew II, Restricted Stock Units, RSU, Insider Transaction, Form 4, Executive Compensation, Equity Grant